a year ago
BMRN
AnalystsWilliam PickeringWilliam Pickering's Stock Forecasts
AnalystsWilliam Pickering
Sectors:
Industries:
Analyst Ranking
Bottom 14%
#4795 out of 5549 analysts
Average Return
-1.4%
Win Rate
52%13 out of 25
Risk vs Reward
Poor
Good
William Pickering's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alnylam Pharmaceuticals IncALNY | +72.24% | $235.95 | $406.40 | 2025-01-07 - 2026-01-06 | Buy |
Vertex Pharmaceuticals IncVRTX | +41.12% | $358.40 | $505.78 | 2023-08-02 - 2024-08-01 | Buy |
Vertex Pharmaceuticals IncVRTX | +39.88% | $354.05 | $495.26 | 2023-07-28 - 2024-07-26 | Buy |
Regeneron Pharmaceuticals IncREGN | +38.82% | $586.96 | $814.79 | 2025-08-27 - 2026-08-26 | Buy |
Vertex Pharmaceuticals IncVRTX | +36.16% | $302.66 | $412.11 | 2023-03-21 - 2024-03-20 | Buy |
William Pickering Analyst Color
Get additional color on William Pickering's coverage of popular stocks
William Pickering's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Intellia Therapeutics IncNTLA | 3 | Hold | $17.00 | +38.44% | Maintains | 5 months ago |
Dyne Therapeutics IncDYN | 1 | Hold | $24.00 | +41.68% | Maintains | 5 months ago |
Crispr Therapeutics AgCRSP | 2 | Hold | $56.00 | +8.80% | Maintains | 5 months ago |
Beam Therapeutics IncBEAM | 3 | Buy | $39.00 | +56.63% | Maintains | 5 months ago |
Arrowhead Pharmaceuticals IncARWR | 3 | Hold | $46.00 | -22.07% | Maintains | 5 months ago |
Biomarin Pharmaceutical IncBMRN | 7 | Buy | $82.00 | +48.15% | Maintains | 6 months ago |
Vertex Pharmaceuticals IncVRTX | 7 | Buy | $572.00 | +9.78% | Maintains | 6 months ago |
Allogene Therapeutics IncALLO | 3 | Hold | $3.85 | +213.01% | Maintains | 6 months ago |
Regeneron Pharmaceuticals IncREGN | 4 | Buy | $921.00 | +12.85% | Maintains | 7 months ago |
Bridgebio Pharma IncBBIO | 1 | Buy | $94.00 | +35.51% | Initiates Coverage On | a year ago |
Biohaven LtdBHVN | 3 | Hold | $9.00 | -41.14% | Downgrades | a year ago |
Biogen IncBIIB | 1 | Hold | $157.00 | -37.88% | Maintains | a year ago |
Avidity Biosciences IncRNAM | 1 | Hold | $72.00 | N/A | Downgrades | a year ago |
Sarepta Therapeutics IncSRPT | 1 | Hold | $13.00 | N/A | Initiates Coverage On | a year ago |
Alnylam Pharmaceuticals IncALNY | 2 | Buy | $310.00 | N/A | Maintains | 2 years ago |
Ionis Pharmaceuticals IncIONS | 2 | Hold | N/A | N/A | Upgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.